Artemis Medicare Services Q4 FY26 Earnings Preview & Outlook
Artemis Medicare Services latest news:
Updated: 25 Mar 2026 • 12:45 pm
Posted by:
Artemis Medicare Services Q4 Results 2026 Preview
- Artemis Medicare Services Q4 FY26 revenue is expected to be around Strong Growth Expected, representing a 16-22% YoY increase compared to the same quarter last year.
- Profit After Tax, or PAT, is projected to rise 18-24% YoY.
- EBITDA to rise 17-23%.
- Artemis Medicare Services is expected to show Strong Growth Expected in its revenue.
Click and Sign Up to Get Live Updates on Q4 Results
Artemis Medicare Services Share Performance
- Over the past six months, Artemis Medicare Services share price has Up by 28% to 227.65.
- Moreover, over the past year, the stock has Up by 48%
- Despite this weak short-term performance, Artemis Medicare Services stock has delivered a financially sound 230% return over the past 5 years.
- As of today, 25-03-2026, the Artemis Medicare Services share price is trading at 227.65 per share.
Key Factors to Watch for Artemis Medicare Services Q4 Results FY26
- Revenue Growth & Segment Performance – Focus on topline growth in the Hospital Services industry within the Healthcare sector.
- Occupancy Levels & Seat Expansion – Monitor operational expansion and capacity utilisation trends.
- Profitability & Margin Trends – Track EBITDA and PAT margins to evaluate cost control and operating efficiency.
- Order Book & New Client Wins – Watch for updates on new contracts, partnerships, and long-term deals.
- Balance Sheet & Cash Flow Position – Review debt levels, working capital management, and operating cash flows for financial stability.
Visit Univest app or website to check more Artemis Medicare Services latest news to make an informed investment decision.
About Artemis Medicare Services
Artemis Medicare operates multi-specialty hospitals delivering advanced healthcare and medical services. The company focuses on high-quality patient care, expanding healthcare infrastructure, and adopting advanced medical technologies, benefiting from rising healthcare demand and increasing patient inflow across its network of hospitals.
Visit Univest app or website to check more Artemis Medicare Services latest news to make an informed investment decision.
Final Thoughts
Artemis Medicare Services is gear up to announce its Q4 FY26 results. Analysts expect 16-22% revenue growth, a 18-24% rise in PAT, and a 17-23% rise in EBITDA. Artemis Medicare Services focuses on revenue growth from order execution, margin improvement, a strong order book, and management.
Stay informed with Univest blogs to get real-time updates on Artemis Medicare Services Q4 results FY26.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Arkade Developers Q4 Results 2026 Preview & Earnings
Arisinfra Solutions Q4 Results 2026 Preview & Earnings
Archidply Industries Q4 results preview with revenue outlook and earnings estimates.
Aqylon Nexus Q4 Results 2026 Preview & Earnings
Apollo Pipes Q4 Results 2026 Preview, Earnings & Demand Outlook
Recent Articles
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
30 October 2026
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
30 October 2026
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
30 October 2026
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
Asian Paints Share Price After Q2 Results: Profit Up 7%, but Price Hikes Are Yet to Brighten Margins
Popular this week
Borosil Share Price Jumps 16% After Strong Q2 Results: Record Profit, Margin Jump and Key Price Levels to Know
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times